Affordable Access

Publisher Website

A disulfide bond replacement strategy enables the efficient design of artificial therapeutic peptides

Authors
Journal
Tetrahedron
0040-4020
Publisher
Elsevier
Publication Date
Volume
70
Issue
42
Identifiers
DOI: 10.1016/j.tet.2014.05.079
Keywords
  • Disulfide Bonds
  • Therapeutic Peptides
  • Amine Cross-Linkages
  • Hydrophobic Tags
  • Bone Resorption-Blocking Activities
Disciplines
  • Engineering
  • Medicine

Abstract

Abstract We demonstrate that disulfide bond replacement is an efficient strategy for engineering therapeutic peptides. In previous work, short peptide fragments, known as WP9QY, with sequence homology with the predicted ligand contact surface of the receptor activator of NF-κB (RANK) were crosslinked through intramolecular disulfide bonds to inhibit RANK ligand (RANKL)-induced signaling, osteoclastogenesis, bone resorption in vitro, and bone loss in vivo. We report that replacement of the disulfide bond of WP9QY with an amine cross-linkage results in a significant improvement in enzymatic stability, with only a slight loss of bone resorption-blocking activity in vitro. Furthermore, the WP9QY derivative inhibits bone loss significantly in vivo, whereas the native form of WP9QY was not effective under the same conditions.

There are no comments yet on this publication. Be the first to share your thoughts.